| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |